Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How should I handle Hong Kong pharmaceutical import and export qualification checks required by cross-border e-commerce platforms?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q490 · Category J: Cross-border pharmaceuticals and industry practice (Q451-Q500)
Cross-border e-commerce platforms generally require sellers to provide Hong Kong pharmaceutical licences and import and export licences as evidence of their legal eligibility to sell medicines. Sellers should prepare all required qualification documents, including pharmaceutical licences, import and export licences and product registration certificates, and proactively cooperate with the platform’s qualification review process. Rengangyongsheng (Hong Kong) Limited recommends establishing a standardised qualification management system to ensure that documents are accurate, valid and updated promptly in response to platform requirements, thereby improving the prospects for successful cooperation and the level of business compliance.

📘 Regulatory basis

Pharmacy and Poisons Ordinance (Cap.138); qualification requirements for cross-border e-commerce platforms

📗 Drew Tang's recommendations

Maintain complete qualification records and proactively cooperate with platform reviews to avoid delays to sales caused by qualification checks

📕 Risk notice

Insufficient qualifications or false information may lead the platform to refuse to work with you, affecting business development.

Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗